Metaproterenol Sulfate
Specifications
5874-97-5CAS Number
227-539-6EC Number
bis(5-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,3-diol);sulfuric acidIUPAC Name
C22H36N2O10SChemical Formula
520.6 g/molMolecular Weight
Metaproterenol sulfate; Orciprenaline sulfate; 5874-97-5; Orciprenaline sulphate; Metaproterenol sulphate; Alupent; Prometa; DTXSID4045391; TH-152; Novasmasol; GJ20H50YF0; DTXCID2025391; 1-(3,5-Dihydroxyphenyl)-2-(isopropylamino)ethanol sulfate; 1-(3,5-Dihydroxyphenyl)-1-hydroxy-2-isopropylaminoethane sulfate; 3,5-Dihydroxy-alpha-((isopropylamino)methyl)benzyl alcohol sulfate; Alupent obstetric; RefChem:56514; CHEBI:83332; 1,3-Benzenediol, 5-(1-hydroxy-2-((1-methylethyl)amino)ethyl)-, Sulfate(2:1)(Salt); 5-((1RS)-1-Hydroxy-2-((1-methylethyl)amino)ethyl)benzene-1,3-diol hemisulfate; 227-539-6; Metaproterenol hemisulfate salt; Metaproterenol hemisulfate; Orciprenaline (hemisulfate); Metaproterenol (hemisulfate); Metaproterenol sulfate, orciprenaline sulfate; Norepinephrine Impurity 35; Metaproterenol sulfate [USAN]; Prestwick_845; Alupent (TN); MFCD00058303; Orciprenaline sulfate CRS; NCGC00016662-01; CAS-5874-97-5; SCHEMBL41815; Metaproterenol sulfate (USP); Orciprenaline sulfate (JP18); MSK1376A; orb1310766; CHEMBL1568057; MKFFGUZYVNDHIH-UHFFFAOYSA-N; HMS1569F11; HMS2096F11; HMS3262C10; HMS3713F11; HMS5083I11; METAPROTERENOL SULFATE [MI]; ORCIPRENALINE SULFATE [JAN]; MSK1376A-1000M; Tox21_110551; Tox21_500734; EBC-15025; METAPROTERENOL SULFATE [VANDF]; ORCIPRENALINE SULFATE [MART.]; 5-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,3-diol;sulfuric acid; AKOS015994757; ORCIPRENALINE SULFATE [WHO-DD]; Tox21_110551_1; CCG-220505; CCG-222038; LP00734; METAPROTERENOL SULFATE [USP-RS]; SS-4263; Orciprenaline for system suitability CRS; NCGC00015655-09; NCGC00094078-01; NCGC00261419-01; DB-053257; METAPROTERENOL SULFATE [ORANGE BOOK]; ORCIPRENALINE SULFATE [EP MONOGRAPH]; EU-0100734; SW198971-2; T0277; EN300-50867; METAPROTERENOL SULFATE [USP MONOGRAPH]; D00685; F82060; M 2398; SR-01000872665; SR-01000872665-1; Q27279120; Z955123630; bis(5-(1-hydroxy-2-(isopropylamino)ethyl)benzene-1,3-diol) sulfate; Metaproterenol hemisulfate salt Solution in Methanol, 1000ug/mL; 5-[1-hydroxy-2-(isopropylamino)ethyl]benzene-1,3-diol;sulfuric acid; Metaproterenol sulfate, United States Pharmacopeia (USP) Reference Standard; Orciprenaline sulfate, European Pharmacopoeia (EP) Reference Standard; (+/-)-3,5-DIHYDROXY-.ALPHA.-((ISOPROPYLAMINO)METHYL)BENZYL ALCOHOL SULFATE (2:1); (+/-)-3,5-DIHYDROXY-.ALPHA.-((ISOPROPYLAMINO)METHYL)BENZYL ALCOHOL SULPHATE (2:1); bis(5-{1-hydroxy-2-[(propan-2-yl)amino]ethyl}benzene-1,3-diol); sulfuric acid; Orciprenaline for system suitability, European Pharmacopoeia (EP) Reference Standard; Sulfuric acid--5-{1-hydroxy-2-[(propan-2-yl)amino]ethyl}benzene-1,3-diol (1/2); 1,3-BENZENEDIOL, 5-(1-HYDROXY-2-(1-METHYLETHYL)AMINO)ETHYL-, (+/-)-, SULFATE (2:1) (SALT); 1,3-BENZENEDIOL, 5-(1-HYDROXY-2-(1-METHYLETHYL)AMINO)ETHYL-, (+/-)-, SULPHATE (2:1) (SALT); Metaproterenol sulfate; 1,3-Benzenediol, 5-[1-hydroxy-2-[(1-methylethyl)amino]ethyl]-, sulfate (2:1)Synonyms
